Aptaas Pharmaceuticals Private Limited
About Aptaas Pharmaceuticals Private Limited
Data last updated:
Aptaas Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 03 May 2013.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2013PTC251521.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Poonam Devi and Deepak Kumar.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at H – 16/104 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110062.
As per the financials filed for FY 2018, the company reported a revenue of ₹4.25 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹29,761 (net margin -7%) and EBITDA of -₹26,752 (EBITDA margin -6.3%).
Company details
Contact details
Aptaas Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressH – 16/104 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110062
- IndustryTrading, Wholesale, Specialty
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aptaas Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aptaas Pharmaceuticals Private Limited, buy the company report.
Financials of Aptaas Pharmaceuticals Private Limited
FY 2018 filings availableAptaas Pharmaceuticals Private Limited reported revenue of ₹4.25 Lakh (down 6% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year. EBITDA rose 63% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹26,752 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹29,761 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -6.3% | |||
| Net Profit Margin | -7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aptaas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aptaas Pharmaceuticals Private Limited
Aptaas Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar | Additional Director | 21 Dec 2018 | 7 Years 10 Months | As last reported |
| Poonam Devi | Director | 08 Jun 2019 | 7 Years 4 Months | As last reported |
Legal cases
No court or tribunal cases involving Aptaas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aptaas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aptaas Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aptaas Pharmaceuticals Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Deepu Biswas ceased to be Director on 08 Jun 2019.
Frequently asked questions
Aptaas Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Aptaas Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in wholesale, within the trading industry. It was incorporated on 03 May 2013 and is registered under CIN U51909DL2013PTC251521. The company has been struck off by the Registrar of Companies and is no longer operational.
Aptaas Pharmaceuticals had 2 directors:
- Deepak Kumar - Additional Director
- Poonam Devi - Director
The CIN (Corporate Identification Number) of Aptaas Pharmaceuticals is U51909DL2013PTC251521. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Aptaas Pharmaceuticals is at H – 16104 Ground Floor Sangam Vihar, New Delhi, Delhi, India – 110062.
Aptaas Pharmaceuticals was incorporated on 03 May 2013. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Aptaas Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
Aptaas Pharmaceuticals operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
Deepu Biswas ceased to be Director on 08 Jun 2019. Poonam Devi was appointed as Director on 08 Jun 2019. Deepak Kumar was appointed as Additional Director on 21 Dec 2018. Aptaas Pharmaceuticals has 6 board changes on record in total.
The compliance status of Aptaas Pharmaceuticals is compliant as of 16 July 2026.